EMERGENT BIOSOLUTIONS INC. Deferred Income Tax Assets, Net
EMERGENT BIOSOLUTIONS INC. (EBS) had Deferred Income Tax Assets, Net of $17.60 million as of 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2020-05-01
- 2020-03-31: Deferred Income Tax Assets, Net $17.60M.
- 2019-12-31: Deferred Income Tax Assets, Net $13.40M.
- 2018-12-31: Deferred Income Tax Assets, Net $13.40M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2020-03-31 | $17.60M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $13.40M 10-Q · filed 2020-05-01 |
| 2018-12-31 | $13.40M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |